All five trials have shown no improvement in mortality or morbidity by aggressively controlling rhythm with antiarrhythmic drugs. The consistency of these findings is truly remarkable if one considers ...

Please provide your email address to receive an email when new articles are posted on . In patients younger than 75 years with atrial fibrillation and concomitant CV conditions, an early rhythm ...

Tackling rhythm control early, with ablation or antiarrhythmic medication in the first year after atrial fibrillation (Afib) diagnosis, helped outcomes in people with heart failure (HF), a ...

Early rhythm control with ablation or antiarrhythmic drugs is associated with a lower risk of adverse cardiovascular outcomes compared with rate control in patients with newly diagnosed atrial ...

(UPDATED) Swift initiation of rhythm-control therapy in patients with recently diagnosed atrial fibrillation in the setting of other cardiovascular conditions reduced the risk of CV events as compared ...

What changed?: The COMPASS initiative boosted early rhythm control use in AF from 28.8% to 32.8% within six months of diagnosis. Specialist access up: Referrals to electrophysiologists rose from 22.6% ...

Early rhythm control improved the combined outcome of death or hospitalization for worsening heart failure, with 91 vs 123 patients in the rhythm control vs standard care group, respectively, ...

The choice of management strategy in patients with recent-onset AF does not affect clinical outcomes, but does influence the likelihood of progression to permanent AF, according to data from an ...

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to new results. Patients with newly diagnosed atrial fibrillation benefit from early rhythm ...

The management of patients with atrial fibrillation involves three main areas: anticoagulation, rate control and rhythm control. Importantly, these are not mutually exclusive of each other.

Antiarrhythmic medications used to maintain sinus rhythm have long been the treatment of choice in atrial fibrillation. The results of five prospective randomized trials comparing the efficacy and ...